In the future, in-depth pathway analysis of ITIH4 through targeted in vitro and in vivo validations are necessary to illuminate and validate the role of ITIH4 in RA, discovering a major protein mediator in RA pathogenesis. Here, ITIH4 is linked to rheumatoid arthritis.